Survival impact of adjuvant treatment in resected stage III cutaneous melanoma patients: Results from a real-life cohort study (TAMARIS).Charlée Nardin, Théo Erard, M. Amini Adle et al.|Journal of Clinical Oncology|2025Cited by 2